CHRS 2023 Call for Abstracts - CALL FOR ABSTRACTS

The CHRS Planning Committee is actively inviting proposals for poster presentations for the in-person 2023 CHRS Annual Meeting in Banff, Alberta. We are looking for stimulating and informative presentations in all areas of interest!

Please provide the following information for the primary/presenting author who should receive correspondence from the CHRS.

Application Deadline: June 5, 2023

AUTHOR CONTACT INFORMATION: *

First Name

Last Name

Credentials

Street Address

City

Province

Postal Code

Email Address

Phone Number

Institution

Program

Program Director/Supervisor

IF YOU ARE A TRAINEE, PLEASE SPECIFY YEARS OF STUDIES:

PLEASE LIST ALL AUTHORS IN THE ORDER THEY SHOULD APPEAR. AUTHORS WITH POTENTIAL CONFLICTS OF INTEREST MUST BE IDENTIFIED WITH A DAGGER (†) AFTER THEIR NAME. *

FIRST ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

SECOND ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

THIRD ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

FOURTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

FIFTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

SIXTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

SEVENTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

EIGHTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

NINTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

TENTH ADDITIONAL AUTHOR INFORMATION: *

First Name

Middle Initial

Last Name

PLEAE NOTE THAT THE ABSTRACT TITLE SHOULD HAVE THE FIRST LETTER OF EACH MAJOR WORD CAPITALIZED. *

ABSTRACT TITLE *

ABSTRACT - no more than 250 words - Abstract will be rejected if this maximum is exceeded. *

The CHRS adheres to the CMA Policy Guidelines for Physicians in Interactions with Industry. CHRS requires prior disclosure if during the CME/CPD event there will be discussion of any unapproved use of a medical product or device, or if trade names will be used. CHRS requires the presenting author to complete this form indicating any financial interest or affiliation within the last two (2) years, with manufacturers of products or devices mentioned at the event or with manufacturers of competing products or devices.

Unapproved Uses of Medical Products or Devices: Physicians prescribe medications and use products and devices for which formal approval has never been granted by Health Canada. The recommendation of unapproved uses during a CPD/CME activity should be identified as such to the audience.

WILL YOU DISCUSS OR RECOMMEND ANY UNAPPROVED USES OF SPECIFIC DRUGS OR OTHER PRODUCTS OR DEVICES?

Yes

If yes, please provide details:

Use of Trade Names: The CMA Policy (Guidelines for Physicians in Interactions with Industry) specifies that generic rather than trade names be used, wherever possible, in presentations materials.

WILL YOU USE ANY TRADE NAMES?

Yes

If yes, please provide details:

Potential Conflicts of Interest: A conflict of interest may exist if a speaker has a financial interest in, or is otherwise affiliated with, a commercial organization that may have a direct or indirect interest in the content of his/her presentation. CHRS requires that all speakers disclose such pertinent relationships and inform participants of these relationships at the time of the CME/CPD event but declaration informs participants of the affiliation so that they may be aware of possible bias on the content.

A "financial interest" may include but is not limited to:

Being a shareholder
Receiving research funding or other support
Receiving fees or other benefits for any role (including speaking at CPD activities)
Being a paid employee or consultant

An "affiliation" may include but is not limited to:

Holding a position in the organization
Sitting on an advisory committee
Playing some other role of benefit to the organization

DO YOU HAVE FINANCIAL INTEREST, AND/OR AFFILIATIONS WITH, COMMERCIAL ORGANIZATIONS THAT HAVE SOME INTEREST IN THE CONTECT OF YOUR PRESENTATION?

Yes

If yes, please describe: *

Organization(s)

Nature of Relationship(s)

Comments

BY CHECKING THE BOX BELOW, I AM GIVING MY DIGITAL SIGNATURE AND VERIFY THAT THE INFORMATION I HAVE SUBMITTED ON THIS FORM IS TRUE AND ACCURATE. *

I Agree

I Disagree

DATE OF SIGNATURE: *

Click the SUBMIT button below to finalize your abstract submission.

The presenting author will receive all correspondence related to the Abstract Submission. If you have any questions or comments, please do not hesitate to contact CHRS Meeting Abstract Coordinator - Treva via email at treva@gemstone-events.com.